Health

High price may keep deflazacort drug out of several patients’ reach

High price may keep deflazacort drug out of several patients’ reach

A drug recently approved by the Food & Drug Administration (FDA) to treat a rare form of muscular dystrophy may be out of reach of many patients due to its hefty price.
Marathon Pharmaceuticals will sell the FDA-approved deflazacort drug under the brand name Emflaza for nearly $89,000 for a year’s worth of treatment. The figure represents 70 times higher price for the drug than what it costs outside the United States.

Debate over Planned Parenthood funding continues

Debate over Planned Parenthood funding continues

U. S. President Donald Trump and other Republicans have threatened to eliminate federal funding for Planned Parenthood because clinics operating under the organization provide abortion services as well.

This Saturday, the debate over the issue will peak with protest rallies across the nation, including at clinics in San Francisco, Redwood City and Napa, demanding "defunding" of Planned Parenthood.

MDA welcomes FDA approval for muscular dystrophy drug

MDA welcomes FDA approval for muscular dystrophy drug

The Muscular Dystrophy Association (MDA) has welcomed the U.S. Food & Drug Administration’s decision to approve Marathon Pharmaceuticals’ deflazacort drug to treat the most common childhood form of muscular dystrophy.

The deflazacort drug, labeled for use by individuals 5 years or older with Duchenne muscular dystrophy (DMD), can be used regardless of genetic mutation. It is third drug in 6 months approved by the FDA for diseases included in MDA’s program.

6-year-old boy performs victory dance to mark end of chemotherapy

6-year-old boy performs victory dance to mark end of chemotherapy

A six-year-old boy who has long been battling cancer donned a Superman T-shirt, performed a cute-as-can-be happy dance and got to ring the chemotherapy bell at the Children’s Hospital of Pittsburgh at University of Pittsburgh Medical Center on Thursday to mark the end of chemotherapy.

Jimmy Spagnolo, who successfully finished a year-long round of chemotherapy, has been battling an inoperable brain tumor since his infancy.

Research brings male contraceptive closer to reality

Research brings male contraceptive closer to reality

While women have a number of effective birth control options, men have to go under the knife to avoid having a baby. But, that could change soon as a new research has shown promising results in the field of male contraception.

In an experiment at the California National Primate Research Center, a team of researchers injected a gel into the sperm ducts of 16 adult male monkeys and found that the gel was effective at preventing pregnancy.

West Virginia health department distributing 8K overdose antidote kits

West Virginia health department distributing 8K overdose antidote kits

In response to increasing incidents of opioid overdoses, the West Virginia Department of Health & Human Resources is distributing 8,000 kits with the lifesaving antidote naloxone to non-EMS first responders.

Announcing the initiative on Monday, State Health Officer & Commissioner of the Bureau for Public Health Dr. Rahul Gupta said in a statement that it was an effort to saving more lives.

Pages